{"id":"https://genegraph.clinicalgenome.org/r/277f744d-ec1a-49cd-a49a-c58b876fa622v1.2","type":"EvidenceStrengthAssertion","dc:description":"*CHD3* was first reported in relation to autosomal dominant Snijders Blok-Campeau syndrome in 2018 (Snijders Blok et al., PMID: 30397230). Snijders Blok-Campeau syndrome is characterized by global developmental delay, delayed speech, intellectual disability, distinctive facial features including macrocephaly, prominent forehead and hypertelorism, hypotonia, and joint laxity. The severity of neurological deficits and non-neurological features is variable. Nineteen variants, including missense, nonsense, and frameshift variants, reported in 19 probands in 4 publications (PMIDs: 30397230, 32483341, 33571694, 34535214) are included in this curation. Of note, c.2953C>T (p.Arg985Trp) is a recurrent variant reported in 6 unrelated probands (PMID: 30397230). More evidence is available in the literature, but the maximum score for genetic evidence has been reached. This gene-disease relationship is also supported by protein interaction and functional assays (PMIDs: 26867680, 31949314). \n\nIn summary, there is definitive evidence supporting the relationship between *CHD3* and autosomal dominant Snijders Blok-Campeau syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on March 2 2022 (SOP version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/277f744d-ec1a-49cd-a49a-c58b876fa622","GCISnapshot":"https://genegraph.clinicalgenome.org/r/0e94c7c1-9c13-4189-8a9f-e9808916526f","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/0e94c7c1-9c13-4189-8a9f-e9808916526f_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2022-09-23T17:59:32.950Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/0e94c7c1-9c13-4189-8a9f-e9808916526f_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2022-03-02T17:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e94c7c1-9c13-4189-8a9f-e9808916526f_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e94c7c1-9c13-4189-8a9f-e9808916526f_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3960f9c0-ce1f-4d99-8d25-0d57d557911d","type":"EvidenceLine","dc:description":"The score was updated since FOXP2 has been implicated in monogenic forms of childhood apraxia of speech. This gene has also been curated definitively for specific language disorder. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08fb85bf-ee05-4bdf-b7bc-76373f5ff4d1","type":"Finding","dc:description":"FOXP2 is a gene that has been shown to have a transcription factor that has been implicated in monogenic forms of CAS, accompanied by wide-ranging language problems, in multiple families and unrelated cases. In a yeast two hybrid assay, DNA was isolated from positive colonies, the cDNAs of the prey constructs were sequenced and BLAST searched was used to identify the proteins encoded by positive colonies. Proteins represented by two or more colonies were listed. CHD3 was found in 4 preys.  ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26867680","rdfs:label":"Summary of yeast two-hybrid results","demonstrates":{"id":"obo:MI_0208"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b548bd87-154d-4c24-8a07-899d700dad90","type":"EvidenceLine","dc:description":"The score for the protein interaction was upgraded since GATAD2B has been definitively curated for severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1f17ff81-9314-4895-95ea-86250de4df7c","type":"Finding","dc:description":"The GATAD2B proteins functions as a subunit within the NuRD complex. GAND-associated missense variants L180P, R414Q, C420S and C420R disrupt binding to NuRD components CHD3/4/5 or MBD2/3","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31949314","rdfs:label":"GAND-associated missense variants L180P, R414Q, C420S and C4","demonstrates":{"id":"obo:MI_0208"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0e94c7c1-9c13-4189-8a9f-e9808916526f_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/de3e23bf-da4a-4b4e-bc81-277fe1e64f00","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/de3e23bf-da4a-4b4e-bc81-277fe1e64f00_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34535214","allele":{"id":"https://genegraph.clinicalgenome.org/r/84265dab-4d13-46dc-a5cb-00ef8f44886c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.3695G>A (p.Gly1232Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA397942628"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/497b68d2-8ee3-4870-b6ad-bfc20b5ebf66","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/497b68d2-8ee3-4870-b6ad-bfc20b5ebf66_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32483341","allele":{"id":"https://genegraph.clinicalgenome.org/r/c9c5f802-6862-47bd-8cfa-817e790699f9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.4243C>T (p.Arg1415Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA397945446"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/58466da7-53d1-42db-bc0f-b33140e8e480","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/58466da7-53d1-42db-bc0f-b33140e8e480_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30397230","allele":{"id":"https://genegraph.clinicalgenome.org/r/d496b29f-d0dc-4d92-8f7a-25aa156da351","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.1369G>T (p.Glu457Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA397939261"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a750d1d4-7c54-4f63-8408-6272edb4ddd3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a750d1d4-7c54-4f63-8408-6272edb4ddd3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30397230","allele":{"id":"https://genegraph.clinicalgenome.org/r/e0aaebda-5fd8-4e3c-8ad3-9d6723b539dd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.2882G>A (p.Gly961Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA397940566"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5ebe3a50-dd43-4b15-a05f-ac732c30feb1","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ebe3a50-dd43-4b15-a05f-ac732c30feb1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30397230","allele":{"id":"https://genegraph.clinicalgenome.org/r/c4443cf7-8702-4f3f-92f8-e80470a740ae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.3477C>A (p.Asn1159Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA397941968"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/5ebe3a50-dd43-4b15-a05f-ac732c30feb1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Radiometric ATP assays. Restriction enzyme accessibility assay. These assays showed that the N1159K impaired ATP hydrolysis and disturbed chromatin remodeling capacities as measured by restriction enzyme accessibility to nucleosomal DNA","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/28b83e56-4a45-4512-b741-caafa691a00f","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28b83e56-4a45-4512-b741-caafa691a00f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32483341","allele":{"id":"https://genegraph.clinicalgenome.org/r/632bad0d-7c20-41d6-8bb3-38e43fdbd919","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.4280G>A (p.Trp1427Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA397945580"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2f94579c-64f1-4ace-87ef-48f60f3d09f7","type":"EvidenceLine","dc:description":"Upgraded because this is a recurrent variant observed in 6 individuals","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f94579c-64f1-4ace-87ef-48f60f3d09f7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30397230","allele":{"id":"https://genegraph.clinicalgenome.org/r/dadb0e6b-08cf-43a9-9f14-c005b309eb34","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.2953C>T (p.Arg985Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA397940726"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/3c97c6e4-b2f8-402a-a3f9-f72c015dd6d1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c97c6e4-b2f8-402a-a3f9-f72c015dd6d1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32483341","allele":{"id":"https://genegraph.clinicalgenome.org/r/be5b8dee-1421-43ce-87ef-6da11b784c85","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.5863G>T (p.Ala1955Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA397951571"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2b2484ec-9930-4800-99d6-c770bd3a7b65","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b2484ec-9930-4800-99d6-c770bd3a7b65_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30397230","allele":{"id":"https://genegraph.clinicalgenome.org/r/440610ee-c181-41b4-896a-21d70313b43c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.2745G>T (p.Leu915Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA397940231"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/2b2484ec-9930-4800-99d6-c770bd3a7b65_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Radiometric ATP assays. Restriction enzyme accessibility assay. These assays showed that the L915P impaired ATP hydrolysis and disturbed chromatin remodeling capacities as measured by restriction enzyme accessibility to nucleosomal DNA","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/01d88506-d092-4fdd-a8cd-cbc7b31f9504","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01d88506-d092-4fdd-a8cd-cbc7b31f9504_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30397230","allele":{"id":"https://genegraph.clinicalgenome.org/r/ac38eb55-e04c-441d-a244-323f9551a8c0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.3472T>C (p.Trp1158Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA397941954"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/01d88506-d092-4fdd-a8cd-cbc7b31f9504_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Radiometric ATP assays. Restriction enzyme accessibility assay. These assays showed that the W1158R impaired ATP hydrolysis and disturbed chromatin remodeling capacities as measured by restriction enzyme accessibility to nucleosomal DNA","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5b32c06d-6952-4f9e-9a00-ba400a01bcb5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b32c06d-6952-4f9e-9a00-ba400a01bcb5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30397230","allele":{"id":"https://genegraph.clinicalgenome.org/r/ded51695-4b40-4587-8cc1-78677c3cf5fa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.3482A>G (p.His1161Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA397941980"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/21c942fa-d03c-47c0-84d9-bb81e33f41dc","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/21c942fa-d03c-47c0-84d9-bb81e33f41dc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32483341","allele":{"id":"https://genegraph.clinicalgenome.org/r/91ad18d1-10e4-4a67-aa7c-90acb148b72f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.1618dup (p.Arg540ProfsTer47)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8362705"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/15db4bfe-8b0c-43d1-a8ae-f543b39aa779","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/15db4bfe-8b0c-43d1-a8ae-f543b39aa779_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33571694","allele":{"id":"https://genegraph.clinicalgenome.org/r/fece93dc-5ced-4710-b6b1-c523f362171d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.2657A>G (p.His886Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/549729"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7f399088-e4cc-4ae9-ae69-dc6a1ee8e982","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7f399088-e4cc-4ae9-ae69-dc6a1ee8e982_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30397230","allele":{"id":"https://genegraph.clinicalgenome.org/r/2e259cf7-a23e-4e98-a093-822b9589a5d4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.2954G>A (p.Arg985Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA397940728"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/700898f2-b7ad-42ed-b9c2-455ed007a6dd","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/700898f2-b7ad-42ed-b9c2-455ed007a6dd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30397230","allele":{"id":"https://genegraph.clinicalgenome.org/r/a4ed6d5b-5745-423e-a2bc-1df9564a0972","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.4073-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA397944729"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/700898f2-b7ad-42ed-b9c2-455ed007a6dd_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutation affects acceptor splice site of intron 26. Skip of exon 27 is very likely.","functionalDataSupport":"No"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/25e69e98-ff62-4c6f-847b-cfcdad4c63dc","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/25e69e98-ff62-4c6f-847b-cfcdad4c63dc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32483341","allele":{"id":"https://genegraph.clinicalgenome.org/r/908db982-56e1-4351-8de1-5281cbddb9ae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000017.11:g.7905097_7905105del (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573102927"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ac48b453-377e-4281-829e-c2a3fa287655","type":"EvidenceLine","dc:description":"This was downgraded because this proband was diagnosed with childhood apraxia of speech (CAS) with no mention of Snijders Blok-Campeau Syndrome and .","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac48b453-377e-4281-829e-c2a3fa287655_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29463886","allele":{"id":"https://genegraph.clinicalgenome.org/r/89eecfe7-6eb4-4fb2-ba7f-6a97be9a2527","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.3505C>T (p.Arg1169Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA397942050"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/89e850d6-7a14-40b3-99e1-df405f3a8572","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/89e850d6-7a14-40b3-99e1-df405f3a8572_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32483341","allele":{"id":"https://genegraph.clinicalgenome.org/r/08c57077-6315-4f78-9148-5d3b107a507e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.1384del (p.Cys462AlafsTer22)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573102926"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/58193392-6f11-4715-b4d1-7dbd32134a85","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/58193392-6f11-4715-b4d1-7dbd32134a85_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30397230","allele":{"id":"https://genegraph.clinicalgenome.org/r/89eecfe7-6eb4-4fb2-ba7f-6a97be9a2527"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/39686162-05f4-4803-b9da-4b14a70df29d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39686162-05f4-4803-b9da-4b14a70df29d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32483341","allele":{"id":"https://genegraph.clinicalgenome.org/r/eaf8aa57-0fda-43a5-b4bf-7ddf5bb7a5bb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001005273.3(CHD3):c.1706A>G (p.Gln569Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA397934442"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":5051,"specifiedBy":"GeneValidityCriteria8","strengthScore":14,"subject":{"id":"https://genegraph.clinicalgenome.org/r/YgvO442f6Mg","type":"GeneValidityProposition","disease":"obo:MONDO_0032600","gene":"hgnc:1918","modeOfInheritance":"obo:HP_0000006"},"version":"1.2","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_0e94c7c1-9c13-4189-8a9f-e9808916526f-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}